The Fresh Toast - Cannabis rescheduling hearing highlights questions about workplace standards and inconsistent treatment of ...

The Fresh Toast - The latest with the marijuana rescheduling hearings reveals one-sided testimony and growing controversy ...

The DEA has begun an administrative hearing to place marijuana in Schedule III of the Controlled Substances Act, which would ...

The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion ...

Without coordinated guidance, patients will continue to suffer and depend on the courts to step in and correct these ...

There was no discussion of the lasting harms of marijuana criminalization itself—the arrests, convictions, incarceration and collateral consequences that continue to affect individuals, families and ...

The rescheduling of medical cannabis to Schedule III has paradoxically created significant uncertainty for banks serving the industry. The decade-old FinCEN guidance, which enabled cannabis banking, ...

The DEA's cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.

The Drug Enforcement Administration is considering a proposal to move marijuana from Schedule I to Schedule III of the ...

The Drug Enforcement Administration is scheduled to hold a historic hearing beginning Monday, June 29, 2026, which could ...

A two-page letter outlined precautions the government agencies should take as the DEA prepares to downgrade marijuana’s ...

Add Yahoo as a preferred source to see more of our stories on Google. A marijuana plant. (Cappi Thompson/Getty Images) Acting Attorney General Todd Blanche signed an order on Thursday reclassifying ...